# Cardiometabolic Disease and Substrate Metabolism

> **NCT07565727** · — · RECRUITING · sponsor: **University of Tennessee Graduate School of Medicine** · enrollment: 50 (estimated)

## Conditions studied

- Preeclampsia
- Gestational Diabetes Mellitus (GDM)
- Preeclampsia (PE)
- Preeclampsia (PE) Risk
- Gestational Diabetes
- Gestational Diabetes Mellitus in Pregnancy
- Cardiometabolic Diseases
- Insulin Resistance
- Placental Dysfunction
- Pregnancy
- Pregnancy Complications
- Gestational Complications

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07565727
- **Lead sponsor:** University of Tennessee Graduate School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-10
- **Primary completion:** 2026-08
- **Final completion:** 2027-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07565727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07565727, "Cardiometabolic Disease and Substrate Metabolism". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07565727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*